Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous-cell Carcinoma
Clinical Skin Cancer · 2016
DOI: 10.1016/j.clsc.2017.04.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Skin Cancer, 2016. Verfasst von Georgia M. Beasley und 8 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Beasley, G. M., Kurtz, J., Vandeusen, J., Howard, J. H., Terando, A., Agnese, D., Liebner, D., Jeter, J., & Olencki, T. (2016). Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous-cell Carcinoma. Clinical Skin Cancer. https://doi.org/10.1016/j.clsc.2017.04.001
Vancouver
Beasley GM, Kurtz J, Vandeusen J, Howard JH, Terando A, Agnese D, et al. Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous-cell Carcinoma. Clinical Skin Cancer. 2016. doi:10.1016/j.clsc.2017.04.001
BibTeX
@article{Beasley2016,
author = {Beasley, Georgia M. and Kurtz, James and Vandeusen, Jeff and Howard, J. Harrison and Terando, Alicia and Agnese, Doreen and Liebner, David and Jeter, Joanne and Olencki, Thomas},
title = {Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous-cell Carcinoma},
journal = {Clinical Skin Cancer},
year = {2016},
doi = {10.1016/j.clsc.2017.04.001}
}
EUVIMED